Hims & Hers Health, UnitedHealth Group, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of companies operating in the healthcare sector—including pharmaceutical and biotechnology firms, medical device manufacturers, and healthcare service providers. They give investors exposure to the industry’s growth potential, which is driven by factors such as regulatory approvals, medical innovations, and demographic trends. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Shares of NYSE HIMS traded up $0.59 during midday trading on Wednesday, reaching $50.06. The company's stock had a trading volume of 55,344,449 shares, compared to its average volume of 27,172,787. The company has a market cap of $11.12 billion, a P/E ratio of 113.78 and a beta of 1.84. The business's 50 day moving average price is $32.39 and its two-hundred day moving average price is $31.82. Hims & Hers Health has a fifty-two week low of $11.64 and a fifty-two week high of $72.98.
Read Our Latest Research Report on HIMS
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Shares of NYSE:UNH traded down $5.49 during trading on Wednesday, reaching $389.02. 4,114,338 shares of the company traded hands, compared to its average volume of 5,964,271. The firm has a market capitalization of $354.10 billion, a PE ratio of 25.08, a PEG ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 52 week low of $387.75 and a 52 week high of $630.73. The company's 50 day moving average is $493.20 and its two-hundred day moving average is $526.12.
Read Our Latest Research Report on UNH
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of NYSE:LLY traded up $4.80 during midday trading on Wednesday, hitting $779.92. The stock had a trading volume of 1,540,889 shares, compared to its average volume of 3,870,855. The company's 50-day moving average price is $820.91 and its 200-day moving average price is $814.03. Eli Lilly and Company has a fifty-two week low of $677.09 and a fifty-two week high of $972.53. The company has a quick ratio of 0.97, a current ratio of 1.15 and a debt-to-equity ratio of 2.00. The company has a market capitalization of $739.16 billion, a P/E ratio of 66.60, a price-to-earnings-growth ratio of 1.40 and a beta of 0.48.
Read Our Latest Research Report on LLY
Further Reading
Before you consider Hims & Hers Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hims & Hers Health wasn't on the list.
While Hims & Hers Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
